Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Al-Dar Al-Arabia Pharmaceutical Manufacturing (ADAPM) is a Jordanian pharmaceutical company dedicated to the development and manufacturing of high-quality generic medicines. The company is particularly recognized for its specialized production of respiratory products, including metered-dose inhalers (MDIs) and dry powder inhalers (DPIs), making it a key player in the regional market for asthma and COPD treatments. In addition to respiratory care, ADAPM produces a diverse range of therapeutic products in solid and liquid oral dosage forms, covering cardiovascular, gastrointestinal, and central nervous system indications. Operating from its manufacturing site in the King Abdullah II Industrial Estate in Sahab, the company adheres to international Good Manufacturing Practice (GMP) standards to supply markets across the Middle East and North Africa (MENA) region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Al-Dar Al-Arabia Pharmaceutical Manufacturing.